Figure 8

Recurrence-free survival in HER2⁺breast cancer patients according to HRG expression levels. Tick marks in Kaplan-Meier estimates of recurrence-free survival indicate patients whose data were censored by the time of last follow-up or owing to death. P < 0.0034 was calculated by using log-rank Mantel-Cox test.